News

The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...
In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.
She spotlighted the “Free to Shine” initiative championed by Nigeria’s First Lady, Senator Oluremi Tinubu, which aims to ...
The initiative is helping to diagnose HIV, Hepatitis B (HBV) and Hepatitis C (HCV), making sure even more people are being ...
The National Health Mission (NHM) and the Himachal Pradesh State AIDS Control Society will lay thrust on the timely screening ...
NACA acknowledged that while donor funding had played a huge role in Nigeria’s HIV response, the country could no longer ...
The mosquito-borne chikungunya is rare in China, but the CDC urges caution and Chinese officials have taken steps compared to ...
The Manila Times on MSN12h
DOH launches HIV campaign in companies
THE Department of Health (DOH) announced on Monday the launch of a human immunodeficiency virus (HIV) awareness campaign targeting the corporate sector.
While federal sexual wellness research funding is cut, Dallas County continues to report high rates of preventable diseases.
The other major complication of HTLV-1 is a rare type of cancer: adult T-cell leukemia/lymphoma (ATL). It’s estimated that ...